Wall Street Rebounds Fueled by AI-Linked Stocks Amid U.S. Shutdown Resolution

• Why Is Wall Street Rallying Today?
• How Are AI Stocks Performing?
• What’s the Deal with Pfizer and Metsera?
• Amazon’s Global Expansion: What’s New?
• Amgen’s Breakthrough: How Significant Is It?
• Marriott and Sonder: What Went Wrong?
• Oracle’s $18 Billion Data Center Project
• Tesla’s Cybertruck Chief Departs: What’s Next?
• FAQs

Wall Street staged a comeback as AI-driven stocks like Nvidia surged, while the U.S. Senate moved to end the longest federal shutdown in history. Key players like Pfizer, Amazon, and Oracle made headlines with major deals and expansions. Here’s a deep dive into the market’s latest moves and what they mean for investors.

Why Is Wall Street Rallying Today?

U.S. indices are climbing thanks to Optimism around the impending resolution of the federal shutdown. Eight Democratic senators are expected to join Republicans in voting for a bill to fund the government until January 30, 2026. This political stability has buoyed markets, with the Dow Jones up 0.02% to 46,994.97 and the Nasdaq Composite jumping 1.42% to 23,330.75. AI-linked stocks, particularly Nvidia, are leading the charge despite recent valuation concerns.

How Are AI Stocks Performing?

Nvidia, a bellwether for AI investments, rebounded after days of pressure over its sky-high valuation. The broader tech sector also gained, with the Nasdaq outperforming. According to BTCC analysts, "AI remains a dominant theme, and any dip in these stocks is seen as a buying opportunity by institutional investors."

What’s the Deal with Pfizer and Metsera?

Pfizer (-0.59% to $24.29) finalized its acquisition of Metsera for up to $86.25 per share, outbidding Novo Nordisk. The deal, initially pegged at $70 per share, will now cost Pfizer over $10 billion, with 75% paid upfront. JPMorgan noted this as a strategic MOVE to bolster Pfizer’s pipeline amid declining COVID-19 revenue.

Amazon’s Global Expansion: What’s New?

Amazon launched its low-cost e-commerce platform, Amazon Bazaar (known as Haul in the U.S.), in 14 countries, including Argentina, Nigeria, and the Philippines. The platform offers over a million items under $10, with many below $5. This expansion aligns with Amazon’s strategy to tap into emerging markets where affordability is key.

Amgen’s Breakthrough: How Significant Is It?

Amgen released Phase 3 trial results for Repatha, showing it significantly reduces major adverse cardiovascular events (MACE) in high-risk adults without prior heart attacks or strokes. When combined with statins, Repatha could revolutionize LDL cholesterol management.

Marriott and Sonder: What Went Wrong?

Marriott terminated its licensing agreement with Sonder Holdings due to contractual breaches. This will reduce Marriott’s net room growth to 4.5% this year. The hotel giant reaffirmed its other financial targets, signaling confidence in its Core operations.

Oracle’s $18 Billion Data Center Project

A consortium of 20 banks, including BNP Paribas and Goldman Sachs, loaned Oracle $18 billion to build a data center campus in New Mexico. Part of the "Stargate" project with OpenAI and SoftBank, this underscores Oracle’s push into cloud infrastructure.

Tesla’s Cybertruck Chief Departs: What’s Next?

Siddhant Awasthi, Cybertruck program director, left Tesla after eight years. His departure follows shareholder approval of Elon Musk’s $56 billion pay package, tied to ambitious performance goals. Awasthi expressed confidence in Tesla’s "next big mission," hinting at undisclosed projects.

FAQs

What caused Wall Street’s rebound?

The market rallied due to progress in ending the U.S. federal shutdown and strong performance by AI-linked stocks like Nvidia.

How much did Pfizer pay for Metsera?

Pfizer’s final offer reached $86.25 per share, totaling over $10 billion—up from the initial $7.3 billion deal.

Which countries did Amazon Bazaar launch in?

Amazon Bazaar debuted in 14 markets, including Argentina, Nigeria, and the Philippines, targeting budget-conscious shoppers.